0000000000568066

AUTHOR

Berat Ebik

showing 2 related works from this author

Low dose of isotretinoin: A comprehensive review

2020

Isotretinoin is a first-generation retinoid initially approved for the treatment of severe cases of acne vulgaris (nodulocystic acne). Because of its broad anti-inflammatory and immunomodulatory properties, it has been used beyond its initial approval in a myriad of other indications. Adverse effects of isotretinoin vary from xerosis to teratogenicity. Herein, we reviewed the literature, through date-unlimited PubMed search, from inception till December 2019, using the following search terms: "low-dose isotretinoin" and "dermatology," "isotretinoin and safety," "isotretinoin, off-label uses," "isotretinoin and male fertility," "isotretinoin, iPLEDGE system," aiming to deliver a therapeutic …

Malemedicine.medical_specialtyNodulocystic acneDermatologyRetinoids030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineAcne VulgarismedicineHumansIsotretinoinskin and connective tissue diseasesAdverse effectIsotretinoinAcnebusiness.industryLow doseGeneral Medicinemedicine.diseaseDermatologyClinical PracticeSafety profileSearch terms030220 oncology & carcinogenesisDermatologic Agentsbusinessmedicine.drugDermatologic Therapy
researchProduct

Comment on “Cheilitis with hemorrhagic crusts of the vermilion lips”

2020

medicine.medical_specialtyCheilitisbusiness.industryFaceHumansMedicineHemorrhageDermatologyVermilionbusinessDermatologyLipInternational Journal of Dermatology
researchProduct